Rheumatology
From the Journals
Certolizumab pegol: Has serious infection risk been overstated?
New registry study contradicts prior findings from a network meta-analysis.
Daily News Podcast
MDedge Daily News: How European data privacy rules may cost you
And a new ranking points physicians toward practice-friendly South Dakota.
Daily News Podcast
MDedge Daily News: Is kratom the answer to the opioid crisis?
And specialists have adverse reactions to drug price proposals.
From the Journals
Axial SpA disease activity remains mostly stable throughout pregnancy
Disease activity, physical functioning seem to be worst later in pregnancy.
News
FDA approves certolizumab label update for pregnancy, breastfeeding
Approval is based on data from the CRIB and CRADLE studies.
From the Journals
Study links RA flares after joint replacement to disease activity, not medications
Ceasing biologics prior to surgery doesn’t seem to make a difference to progression afterward.
From the Journals
Allopurinol dose not escalated enough to reduce mortality
A small increase in all-cause mortality was seen with dose escalation, but only 10% of patients exceeded 300 mg allopurinol daily.
Daily News Podcast
MDedge Daily News: MedPAC targets Medicare’s pay plans
And a gout drug has a puzzling link to cardiovascular deaths.
News from the FDA/CDC
Arthritis limits physical activity the most in the South
Physical inactivity rates among arthritis patients ranked highest in southern states.
Conference Coverage
Febuxostat increases cardiovascular mortality in CARES trial
ORLANDO – FDA-mandated postmarketing safety study raises safety concerns about the gout drug.
Podcasts
MDedge Daily News: Could gut bacteria trigger autoimmune diseases?
And why confusion reigns over the COPD-asthma overlap.